U.S. market Closed. Opens in 1 day 3 hours 22 minutes

KNSA | Kiniksa Pharmaceuticals, Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue270.26M220.18M38.54MN/AN/AN/AN/AN/A
Cost of Revenue56.52M46.97M9.10M3.81M3.28M286.00K28.00K22.00K
Gross Profit213.74M173.21M29.44M-3.81M-3.28M-286.00K-28.00K-22.00K
Operating Expenses238.93M163.44M186.08M157.36M169.96M108.16M65.40M24.00M
Selling, General & Admin129.43M97.95M85.95M45.32M34.96M21.56M9.04M6.56M
Research & Development76.10M65.49M99.30M112.04M135.00M86.60M56.36M17.44M
Other Operating Expenses33.41M1.25M835.00KN/AN/AN/AN/AN/A
Operating Income-25.20M7.37M-156.64M-157.36M-169.96M-108.16M-65.40M-24.00M
Other Expenses / Income8.54M1.25M97.00K1.13M6.05M4.72M529.00K65.00K
Before Tax Income-16.65M11.03M-156.54M-156.23M-163.91M-103.44M-64.87M-23.94M
Income Tax Expenses-30.74M-172.34M1.39M5.15M-2.05M-214.00K2.00K36.00K
Net Income14.08M183.36M-157.92M-161.38M-161.87M-103.23M-64.87M-23.97M
Interest ExpensesN/A1.25MN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding70.06M69.38M68.58M61.84M54.05M29.55M32.47M32.47M
Diluted Shares Outstanding71.92M70.42M68.58M61.84M54.05M29.55M32.47M32.47M
EBITDA-22.86M9.77M-154.28M-152.42M-167.90M-107.87M-65.37M-23.98M
EBITDA Margin-8.46%4.44%-400.27%0.00%0.00%0.00%0.00%0.00%
EBIT-16.65M12.28M-156.54M-156.23M-163.91M-103.44M-64.87M-23.94M
EBIT Margin-6.16%5.58%-406.13%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙